Category: Antisense & RNAi Technology
Europe Antisense & RNAi Technology
-
Rnai Technology Market, By Application (Drug Discovery and Development, Therapeutics, Functional Genomics, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs & CMOs, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Asia Pacific, Middle East & Africa) Global RNAi technology market growth is driven by growing applications of RNA interference technology in therapeutics development and research. RNA interference or RNAi refers to the process of gene ... Read More
-
Germany Rna Interference (Rnai) Drug Delivery Market Forecast 2024-2032
... to reach a revenue of $23164.24 million by 2032. MARKET INSIGHTS The Germany RNA interference (RNAi) drug delivery market is experiencing significant growth, driven by the increasing demand for RNAi therapeutics. This surge in demand ... Read More
-
United Kingdom Rna Interference (Rnai) Drug Delivery Market Forecast 2024-2032
... is set to reach a revenue of $20807.84 million by 2032. MARKET INSIGHTS The United Kingdom RNA interference (RNAi) drug delivery market is witnessing a notable surge in demand, primarily driven by the increasing adoption ... Read More
-
Poland RNAi Therapeutics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Poland market. Also, factors that are driving and restraining the RNAi therapeutics market are highlighted in the study. ... Read More
-
Germany RNAi Therapeutics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Germany market. Also, factors that are driving and restraining the RNAi therapeutics market are highlighted in the study. ... Read More
-
France RNAi Therapeutics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the France market. Also, factors that are driving and restraining the RNAi therapeutics market are highlighted in the study. ... Read More
-
Ireland RNAi Therapeutics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Ireland market. Also, factors that are driving and restraining the RNAi therapeutics market are highlighted in the study. ... Read More
-
United Kingdom RNAi Therapeutics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... Kingdom market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the United Kingdom market. Also, factors that are driving and restraining the RNAi therapeutics market are ... Read More
-
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Treatment Market, By Type (Hereditary Transthyretin Amyloidosis (hATTR), Wild Type Transthyretin Amyloidosis (wtATTR)), By Drug Type (Transthyretin Stabilizers, Nonsteroidal Anti-Inflammatory Drugs (NSAID), RNAi Therapy, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific) Transthyretin amyloid ardiomyopathy (ATTR-CM) is a rare and serious medical condition characterized by the abnormal accumulation of transthyretin ... Read More
-
US and Europe Gene Editing Market Forecast to 2030 - Country Analysis by Technology [CRISPR, TALEN, Antisense, Zinc Finger Nucleases (ZFNs), and Others], Product and Service (Reagents and Consumables, Instruments, and Others), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical & Biotechnology Companies, Academic and Research Institutes, Clinical Research Organizations, and Others)
... Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical & Biotechnology Companies, Academic and Research Institutes, Clinical Research Organizations, and Others) The US & EU gene editing market is projected to ... Read More
-
Europe Genome Editing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CRISPR, TALEN, Antisense, and Other), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)
... (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations) The genome editing market in Europe is expected to grow from US$ 1,487.30 million in 2021 to US$ 4,791.46 million by 2028; it ... Read More
-
Europe RNA Based Therapeutic Market By Type (RNA Antisense and RNA Interference (RNAi)), By Application (Genetic disorders and Auto immune disorders), By End User (Research Institutes and Hospitals & Clinics), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027
... Industry Forecast, 2021 - 2027 The Europe RNA Based Therapeutic Market would witness market growth of 14.9% CAGR during the forecast period (2021-2027). RNA-based therapies have been investigated as a possible treatment option for difficult-to-treat ... Read More